BoxGroup: The Quiet New York Seed Firm Behind Plaid, Warby Parker and Ramp

The most influential seed investor you have never heard of might be BoxGroup. The New York firm's homepage says it plainly: "Investing in dreams at the earliest stage." Founded in the late 2000s by David Tisch and Adam Rothenberg, BoxGroup spent its first decade investing solely the partners' own money — and has since become one of the most prolific early-stage firms in the United States.

BoxGroup's first outside capital came in October 2019: two funds totalling $165M — BoxGroup Four, a seed fund, and a companion opportunity fund, $82.5M each. In August 2021 it closed $255M across BoxGroup Five ($127.5M) and BoxGroup Strive ($127.5M), its second opportunity fund. Its LP base includes endowments, foundations and family offices.

The model is deliberately lightweight. BoxGroup writes collaborative seed cheques of $250K–$1M — 40–50 new companies a year — participates rather than leads, and does not take board seats. As Tisch puts it, the firm prides itself on being "that first yes": backing founders repeatedly, sometimes backing just ideas and people. The firm is sector-agnostic, describing itself as generalists across consumer, enterprise, fintech, healthcare, marketplaces, synthetic biology and climate, plus developer tools and frontier tech.

The investing team is led by Tisch and Rothenberg alongside investors including Nimi Katragadda and Greg Rosen. There is no accelerator, no demo day and no formal perks programme — the value proposition is speed, access and the firm's formidable founder network. Remarkably, the partners funded the firm entirely from their own pockets for roughly its first decade before raising outside capital in 2019.

The portfolio is where BoxGroup's quiet power shows. It was the first firm to write Plaid a cheque; it was PillPack's first investor before Amazon's acquisition; it pre-seeded Ro and funded every round through its $500M raise at a $5B valuation. Other early bets include Warby Parker, Stripe, Flexport, Ramp, Airtable, ClassPass and Glossier. Exits include Flatiron Health to Roche for $2.1B and Harry's to Edgewell for $1.37B. Newer homepage names such as Cursor and Clay show the firm is still finding breakout companies early.